Rothstein, B. “Topical JAK Inhibitor Ruxolitinib for Vitiligo Treatment”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, pp. S110-S111, doi:10.25251/skin.2.supp.102.